VEGFA and thyroid gland undifferentiated (anaplastic) carcinoma: In human anaplastic thyroid carcinoma cells, Triptolide significantly reduces the expression of the NF-kappa B target genes cyclin D1, vascular endothelial growth factor (VEGF), and urokinase-type plasminogen activator [8].